Bioventus (BVS)
NASDAQ:BVS
US Market

Bioventus (BVS) Financial Statements

114 Followers

Bioventus Financial Overview

Bioventus's market cap is currently ―. The company's EPS TTM is $-0.343; its P/E ratio is -21.73; Bioventus is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $0.07. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Apr 23
Income Statement-
Total Revenue$ 129.46M$ 135.42M$ 120.79M$ 137.07M$ 119.06M
Gross Profit$ 88.38M$ 86.30M$ 78.85M$ 89.12M$ 73.92M
EBIT$ -4.85M$ -8.18M$ -7.96M$ -4.12M$ -90.47M
EBITDA$ 6.93M$ 4.29M$ 5.87M$ 10.48M$ -88.34M
Net Income Common Stockholders$ -4.57M$ -6.10M$ -7.30M$ -3.68M$ -103.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.17M$ 36.96M$ 26.83M$ 29.39M$ 47.10M
Total Assets$ 794.24M$ 810.91M$ 811.10M$ 836.96M$ 887.40M
Total Debt$ 391.24M$ 394.85M$ 394.62M$ 385.89M$ 445.58M
Net Debt$ 366.07M$ 357.88M$ 367.79M$ 356.50M$ 398.48M
Total Liabilities$ 576.81M$ 589.79M$ 584.65M$ 603.62M$ 647.04M
Stockholders Equity$ 171.28M$ 173.59M$ 177.53M$ 183.18M$ 188.50M
Cash Flow-
Free Cash Flow$ -6.30M$ 10.01M$ -10.35M$ 9.40M$ 1.10M
Operating Cash Flow$ -6.00M$ 10.37M$ -8.31M$ 10.79M$ 4.66M
Investing Cash Flow$ -1.00M$ -591.00K$ -2.04M$ 45.01M$ -15.07M
Financing Cash Flow$ -4.24M$ -14.00K$ 8.23M$ -62.25M$ 27.38M
Currency in USD

Bioventus Earnings and Revenue History

Bioventus Debt to Assets

Bioventus Cash Flow

Bioventus Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis